Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing